{"transactions":[{"id":837644,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-17T22:01:47.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":148,"price":22.08,"value":3267.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.97 to $22.16, inclsuive. The reporting person undertakes to provide Neurogene Inc. the Company, any securityholder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) 6,797 restricted stock units granted on March 13, 2025, which will vest on March 13, 2027; (b) 7,200 restricted stock units granted on March 23, 2025, which will vest annually in equal installments on March 23, 2026, March 23, 2027 and March 23, 2028 and (c) 16,500 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":30497,"source":{"system":"sec-edgar","filing":"0001994301-26-000004","document":"wk-form4_1773784904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000199430126000004/wk-form4_1773784904.xml","form_type":"4"}},{"id":837643,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-17T22:01:47.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":2658,"price":21.34,"value":56721.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.97 to $21.96, inclusive. The reporting person undertakes to provide the Company, any securityholder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) 6,797 restricted stock units granted on March 13, 2025, which will vest on March 13, 2027; (b) 7,200 restricted stock units granted on March 23, 2025, which will vest annually in equal installments on March 23, 2026, March 23, 2027 and March 23, 2028 and (c) 16,500 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":30645,"source":{"system":"sec-edgar","filing":"0001994301-26-000004","document":"wk-form4_1773784904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000199430126000004/wk-form4_1773784904.xml","form_type":"4"}},{"id":837642,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-17T22:01:47.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":3991,"price":20.41,"value":81456.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.94 to $20.93, inclusive. The reporting person undertakes to provide Neurogene Inc. (the \"Company\"), any securityholder of the Company, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) 6,797 restricted stock units granted on March 13, 2025, which will vest on March 13, 2027; (b) 7,200 restricted stock units granted on March 23, 2025, which will vest annually in equal installments on March 23, 2026, March 23, 2027 and March 23, 2028 and (c) 16,500 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":33303,"source":{"system":"sec-edgar","filing":"0001994301-26-000004","document":"wk-form4_1773784904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000199430126000004/wk-form4_1773784904.xml","form_type":"4"}},{"id":884493,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-24T23:49:39.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consist of 16,500 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consist of (a) 13,594 restricted stock units remaining from a grant of 20,391 restricted stock units granted on March 13, 2024, which vests annually in equal installments on March 13, 2025, March 13, 2026 and March 13, 2027; (b) 7,200 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (c) 16,500 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":37294,"source":{"system":"sec-edgar","filing":"0001994301-26-000002","document":"wk-form4_1771976976.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000199430126000002/wk-form4_1771976976.xml","form_type":"4"}},{"id":1147228,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-15T20:43:07.000Z","date":"2025-05-14","kind":"sale","planned":true,"acquired":false,"shares":6797,"price":15.1542,"value":103003.0974,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.78 to $15.75. The reporting person undertakes to provide Neurogene Inc. (the \"Company\"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20794,"source":{"system":"sec-edgar","filing":"0001404644-25-000046","document":"wk-form4_1747341779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464425000046/wk-form4_1747341779.xml","form_type":"4"}},{"id":1188769,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2025-03-29T01:30:38.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":42900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 42,900 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal month installments through the fourth anniversary of the grant date."}],"balance_after":42900,"derivative":{"exercise_price":16.14,"expiration_date":"2035-03-26","underlying":"Common Stock","underlying_shares":42900},"source":{"system":"sec-edgar","filing":"0001404644-25-000025","document":"wk-form4_1743211830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464425000025/wk-form4_1743211830.xml","form_type":"4"}},{"id":1188768,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-29T01:30:38.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 7,200 restricted stock units, which will vest in three equal annual installments beginning with the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":27591,"source":{"system":"sec-edgar","filing":"0001404644-25-000025","document":"wk-form4_1743211830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464425000025/wk-form4_1743211830.xml","form_type":"4"}},{"id":1576489,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-15T00:51:43.000Z","date":"2024-03-13","kind":"grant","planned":false,"acquired":true,"shares":34450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date."}],"balance_after":34450,"derivative":{"exercise_price":36.06,"expiration_date":"2034-03-13","underlying":"Common Stock","underlying_shares":34450},"source":{"system":"sec-edgar","filing":"0001404644-24-000006","document":"wk-form4_1710463892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464424000006/wk-form4_1710463892.xml","form_type":"4"}},{"id":1576488,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":59934,"kind":"person","name":"Cobb Stuart","position":1,"cik":"0001994301","reported_name":"Cobb Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-15T00:51:43.000Z","date":"2024-03-13","kind":"grant","planned":false,"acquired":true,"shares":20391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20391,"source":{"system":"sec-edgar","filing":"0001404644-24-000006","document":"wk-form4_1710463892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464424000006/wk-form4_1710463892.xml","form_type":"4"}}]}